[HTML][HTML] Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective …

…, C Domingo-Vila, TS Hayday, C Graham… - The Lancet …, 2021 - thelancet.com
Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…

The polymorphic epithelial mucin MUC1 in human endometrium is regulated with maximal expression in the implantation phase

NA Hey, RA Graham, MW Seif… - The Journal of Clinical …, 1994 - academic.oup.com
After ovulation, progesterone stimulates a temporally regulated secretory transformation in
human endometrial epithelium. Using a combination of immunohistochemistry, and Western …

MUC1 and the immunobiology of cancer

…, JM Burchell, T Plunkett, R Graham… - Journal of mammary …, 2002 - Springer
The membrane epithelial mucin MUC1 is expressed at the luminal surface of most simple
epithelial cells, but expression is greatly increased at lactation and in most breast carcinomas. …

Latest developments in MUC1 immunotherapy

…, JM Burchell, R Graham… - Biochemical Society …, 2018 - portlandpress.com
Currently, there is renewed interest in attempting to recruit the host immune system to eliminate
cancers, and within this renewed activity, MUC1 continues to arouse interest. MUC1 has …

Human endometrial MUC1 carries keratan sulfate: characteristic glycoforms in the luminal epithelium at receptivity

JD Aplin, NA Hey, RA Graham - Glycobiology, 1998 - academic.oup.com
MUC1 is a high molecular mass, highly glycosylated epithelial apical glycoprotein that has
been shown to exhibit both adhesive and anti-adhesive properties. Its expression in human …

O-linked mucin-type glycosylation in breast cancer

JM Burchell, R Beatson, R Graham… - Biochemical Society …, 2018 - portlandpress.com
Changes in mucin-type O-linked glycosylation are seen in over 90% of breast cancers
where increased sialylation is often observed and a change from branched glycans to linear …

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority …

…, T Alaguthurai, C Domingo-Vila, TS Hayday, C Graham… - MedRxiv, 2021 - medrxiv.org
Background The efficacy and safety profile of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) have not been definitively established in …

The polymorphic epithelial mucin: potential as an immunogen for a cancer vaccine

RA Graham, JM Burchell… - Cancer Immunology …, 1996 - Springer
The identification and cloning of several tumour antigens together with an improvement in
the understanding of the mechanisms involved in antigen presentation and immune …

Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells

…, T Link, FJ Olson, H Karlsson, R Graham… - Biochemical …, 2003 - portlandpress.com
We have developed an expression system for the production of large quantities of recombinant
MUC1 mucin in CHO-K1 (Chinese-hamster ovary K1) cells. The extracellular part of …

[HTML][HTML] Serum-derived extracellular vesicles from breast cancer patients contribute to differential regulation of T-cell-mediated immune-escape mechanisms in breast …

R Graham, P Gazinska, B Zhang, A Khiabany… - Frontiers in …, 2023 - frontiersin.org
Background Intracellular communication within the tumour is complex and extracellular
vesicles (EVs) have been identified as major contributing factors for the cell-to-cell …